In recent years, in order to further accelerate the pace of development and development of the new product, the company strengthened its cooperation with internationally renowned pharmaceutical companies and research institutions. In 2012, it signed the technology authorization and cooperation agreement with Taiwan Taijing Biological Technology Co., Ltd. and Taijing Biomedical Research and Development (Beijing) Co., Ltd. and obtained the exclusive patent license of the 1.1 class innovation medicine fluorine-free quinolone "nemonoxacin" within the territory of China. Its oral ...


At present, Zhejiang Medicine Co. Ltd. is specialized in the large-scale production of fat-soluble vitamins, quasi-vitamins, quino-lone antibiotics, anti-drug-resistant antibiot- ics and other products. Its output of vitamin E is the largest domestically, and the 2nd largest globally; the output of Vancomycin hydrochloride accounts for more than 40% of the global production.

网络六人炸金花规律 排列三组选六2468 幸运飞艇两面盘下载 三公扑克牌最新感应器 赛车pk10官网开奖记录 北京pk10冠亚和值计划 七星彩怎么算的很准 二八杠生死门看牌算法 北京pk10亚军走势图 1136倍投方法 扑克三公玩法 北京pk赛车一期计划免费版 排三组选投资 时时彩助赢软件 三分pk10稳赚技巧 双色球透走势图